Paul discusses how L DopA, a precursor for dopamine used in Parkinson's treatment, may actually accelerate the disease by incorporating into proteins, leading to aggregation and misfolding. He raises the controversial question of whether non-protein amino acids in our diet, like L DopA, could trigger autoimmune reactions causing damage to brain neurons, potentially contributing to Parkinson's disease.
